Products DOTAREM
DOTAREM Approved Completed 📈 Rising Magnetic Resonance Imaging
Magnetic Resonance Imaging
Mar 1, 2015 → Oct 1, 2015
About DOTAREM DOTAREM is a approved stage product being developed by Guerbet for Magnetic Resonance Imaging. The current trial status is completed. This product is registered under clinical trial identifier NCT02411201. Target conditions include Magnetic Resonance Imaging.
Clinical Trials (5) NCT ID Phase Status Start Completion Indication NCT03023566 Pre-clinical Completed Feb 9, 2017 Nov 12, 2017 Brain Diseases NCT02411201 Approved Completed Mar 1, 2015 Oct 1, 2015 Magnetic Resonance Imaging NCT01010932 Phase 3 Completed Oct 1, 2009 Dec 1, 2010 Cerebral Arterial Diseases NCT01012674 Phase 3 Completed Oct 1, 2009 Dec 1, 2010 Cerebral Arterial Diseases NCT00980681 Phase 3 Terminated Sep 1, 2009 Dec 1, 2010 Renal Disease
Product Company Stage Hype Score HRS-9231 + Gadobutrol Jiangsu Hengrui Medicine Phase 2 D1000078 + D1000082 + D1000083 + D1000085 AstraZeneca Phase 1 Gadobutrol (Gadavist/Gadovist, BAY86-4875) Bayer Pre-clinical Gadobutrol (Gadovist, BAY86-4875) + Gadopentetate Dimeglumine (Magnevist, BAY86-4882) Bayer Phase 3 Gadoquatrane (BAY1747846) Bayer Phase 3 Gadopentetate dimeglumine (Magnevist, BAY86-4882, SH L 451A) + Gadopentetate dimeglumine (Magnevist, BAY86-4882, SH L 451A) Bayer Phase 2 GBCAs Bayer Pre-clinical Gadobutrol (Gadovist, BAY86-4875) Bayer Phase 3 BAY1747846 Bayer Phase 1 Gadoterate (Dotarem/Clariscan) + Gadobutrol (Gadavist/Gadovist, BAY86-4875) Bayer Approved Gadoquatrane (BAY1747846) + Gadobutrol + Gadoterate meglumine + Gadoteridol Bayer Phase 3 Gadobutrol (Gadovist, BAY86-4875) Bayer Pre-clinical Gadopentetate dimeglumine (Magnevist, BAY86-6661) Bayer Phase 3 Gadoquatrane (BAY1747846) + Gadobutrol + Gadoterate meglumine + Gadoteridol Bayer Phase 3 Gadobutrol (Gadavist, Gadovist, BAY86-4875) Bayer Phase 1 Gadobutrol (Gadovist, BAY86-4875) Bayer Pre-clinical Gadobutrol (Gadavist, BAY86-4875) Bayer Phase 1 BAY1747846 + Matching placebo Bayer Phase 1 Gadoquatrane (BAY1747846) 0.03 mmol Gd/kg + Gadoquatrane (BAY1747846) 0.1 mmol Gd/kg + Matching placebo Bayer Phase 1 Gadobutrol (Gadavist/Gadovist, BAY86-4875) Bayer Pre-clinical
Other Products from Guerbet